| Code | 27028 | ||||||||||
| MA number | 43/0397/92-S | ||||||||||
| Product Form: | cps 50x250 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Dr. Falk Pharma GmbH, Germany | ||||||||||
| Therapeutic Class: | 43 - CHOLERETICA, CHOLEKINETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 24.07.1992 |
| PIL: |
PIL_Ursofalk 250 mg kapsuly_06_2025.pdf
|
| SPC: |
SPC_Ursofalk 250 mg kapsuly_06_2025.pdf
|
| Safety feature | Yes |
| Data update: | 15.04.2019 |
